YORK, Pa., Nov. 11, 2014 /PRNewswire/ -- Unilife Corporation
("Unilife" or "Company") (NASDAQ: UNIS;
ASX: UNS), a developer and supplier of injectable drug delivery
systems, today announced that it has submitted for filing its 10-Q
report for the first quarter of Fiscal Year 2015 ending
September 30, 2014. Due to Veteran's
Day in the U.S., the Securities Exchange Commission ("SEC)" is
closed today. The 10-Q will be available publicly on Wednesday
morning prior to market open. As an interim measure, the Company
has placed the 10-Q onto its website where it may be accessed at
http://ir.unilife.com or via this link.
About Unilife Corporation
Unilife Corporation (NASDAQ:
UNIS / ASX: UNS) is a U.S. based developer and commercial supplier
of injectable drug delivery systems. Unilife's broad portfolio of
proprietary technologies includes prefilled syringes with automatic
needle retraction, drug reconstitution delivery systems,
auto-injectors, wearable injectors, ocular delivery systems and
novel systems. Each of these innovative and highly differentiated
platforms can be customized to address specific customer, drug and
patient requirements. Unilife's global headquarters and
state-of-the-art manufacturing facilities are located in
York, PA. For more information,
please visit www.unilife.com or download the Unilife IRapp on your
iPhone, iPad or Android device.
Forward-Looking Statements
This press release
contains forward-looking statements. All statements that address
operating performance, events or developments that we expect or
anticipate will occur in the future are forward-looking
statements. These forward-looking statements are based on
management's beliefs and assumptions and on information currently
available to our management. Our management believes that these
forward-looking statements are reasonable as and when made.
However, you should not place undue reliance on any such
forward-looking statements because such statements speak only as of
the date when made. We do not undertake any obligation to publicly
update or revise any forward-looking statements, whether as a
result of new information, future events or otherwise, except as
required by law. In addition, forward-looking statements are
subject to certain risks and uncertainties that could cause actual
results, events and developments to differ materially from our
historical experience and our present expectations or projections.
These risks and uncertainties include, but are not limited to,
those described in "Item 1A. Risk Factors" and elsewhere
in our Annual Report on Form 10-K and those
described from time to time in other reports which we file with the
Securities and Exchange Commission.
General: UNIS-G
Investor
Contacts
(US):
|
Analyst
Enquiries
|
Investor
Contacts (Australia)
|
Todd Fromer / Garth
Russell
|
Leigh
Salvo
|
Jeff
Carter
|
KCSA Strategic
Communications
|
Westwicke
Partners
|
Unilife
Corporation
|
P: + 1 212-682-6300
|
P: + 1
415-513-1281
|
P: + 61 2 8346
6500
|
SOURCE Unilife Corporation